Gennex Laboratories Limited (BOM:531739)
India · Delayed Price · Currency is INR 10.71
-0.09 (-0.83%)
At close: Jun 16, 2026
Gennex Laboratories Market Cap
Gennex Laboratories has a market cap or net worth of 2.6 billion as of June 16, 2026. Its market cap has decreased by -19.72% in one year.
Market Cap
2.60B
Enterprise Value
2.97B
Revenue
1.73B
Ranking
n/a
PE Ratio
14.06
Stock Price
10.71
Market Cap Chart
Since January 2, 2002, Gennex Laboratories's market cap has increased from 61.80M to 2.60B, an increase of 4,110.07%. That is a compound annual growth rate of 16.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 2.60B | -20.00% |
| Dec 31, 2025 | 3.25B | -12.43% |
| Dec 31, 2024 | 3.71B | 24.52% |
| Dec 29, 2023 | 2.98B | 160.77% |
| Dec 30, 2022 | 1.14B | -18.17% |
| Dec 31, 2021 | 1.40B | 135.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medico Remedies | 3.56B |
| Trident Lifeline | 2.97B |
| Medicamen Biotech | 2.92B |
| Astonea Labs | 2.56B |
| Sat Kartar Life | 2.53B |
| Ambalal Sarabhai Enterprises | 2.48B |
| Everest Organics | 2.48B |
| BDH Industries | 2.32B |